Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fidia Spa ( (IT:FDA) ) has issued an update.
Fidia S.p.A. has completed the tenth tranche of its reserved POC convertible bond loan with Global Growth Holding Limited, which subscribed 25 bonds for a nominal €250,000, fully paid in cash, and received 35,714,285 attached warrants exercisable over 60 months. The warrants, which are not listed and currently carry an exercise price of €0.007 per share, bring the total outstanding but unexercised POC warrants to 148,422,285, reinforcing GGHL’s potential future equity exposure.
On the same date, GGHL requested and obtained conversion of the 25 bonds at €0.003 per share, resulting in the issuance of 83,333,333 new Fidia shares that will be admitted directly to trading under an existing prospectus. Following this transaction, the POC is fully subscribed for €2.5 million, Fidia’s share capital rises by €250,000 to €12,347,761.90, and the total number of shares increases to 416,078,638, marking a significant equity strengthening and dilution event for existing shareholders.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high‑performance integrated milling systems. The group serves primarily the automotive mould and aerospace sectors, offering numerical controls, high‑speed milling systems and CAM software that cover the full milling process from programming to finished product.
Average Trading Volume: 7,039,678
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.76M
See more insights into FDA stock on TipRanks’ Stock Analysis page.